Trump Weighs Fast-Tracking U.K. Covid Vaccine Before Election: FT
- One option may grant emergency use for AstraZeneca vaccine: FT
- HHS spokesman says pre-election authorization claim is false
The Jenner Institute, the home of a University of Oxford human trial for a coronavirus vaccine, stands in Oxford, U.K., on July 20.
Photographer: David Levenson/BloombergThis article is for subscribers only.
The Trump administration is considering whether to bypass normal U.S. regulatory standards to fast-track an experimental coronavirus vaccine from the U.K. for use in America ahead of the presidential election, the Financial Times reported, citing three unnamed people briefed on the plan.
One option is to issue an “emergency use authorization” in October to a vaccine being developed by AstraZeneca Plc and Oxford University, based on the results from a relatively small U.K. study if it is successful, the people told the British newspaper.